Price Performance
- Day's Low
- ₹1,158.10
- Day's High
- ₹1,195.60
₹ 1,162.70
- 52-w low
- ₹707.15
- 52-w high
- ₹1,284.95
1,162.70
- Day's open
₹1,185 - Previous close
₹1,189.30 - VWAP
₹1,174.27 - Lower price band
₹951.45 - Upper price band
₹1,427.15
Today's Market Action
The last traded share price of Alembic Pharmaceuticals Ltd was 1,162.70 down by -2.24% on the NSE. Its last traded stock price on BSE was 1,161.80 down by -2.27%. The total volume of shares on NSE and BSE combined was 54,053 shares. Its total combined turnover was Rs 6.35 crores.
Medium and Long Term Market Action
Alembic Pharmaceuticals Ltd hit a 52-week high of 1,284.95 on 08-08-2024 and a 52-week low of 707.15 on 31-10-2023.
The stock price of Alembic Pharmaceuticals Ltd is up by 10% over the last one month. It is up by 48.5% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 23377
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Alembic Pharmaceuticals Ltd?
What is the Market Cap of Alembic Pharmaceuticals Ltd?
What is PE Ratio of Alembic Pharmaceuticals Ltd?
What is PB Ratio of Alembic Pharmaceuticals Ltd?
What is the CAGR of Alembic Pharmaceuticals Ltd?
How to Buy Alembic Pharmaceuticals Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Above Average Sustainable RoE
Great Cash Conversion of Profits
Cons
Highly Cyclical Industry
Capital Intensive Business
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(19/09/2024)
(19/09/2024)
91
84.21%
84.21% People are bullish about Alembic Pharmaceuticals Ltd
15.79%
15.79 % People are bearish about Alembic Pharmaceuticals Ltd